Beijing CDC： ＂Superfungi＂ pose no threat to public health.

　　Beijing, April 11 (Xinhua) Recently, a news about "super fungi" triggered a heated discussion in society. The Beijing Municipal Center for Disease Control and Prevention announced today that the "super fungus" is Candida auricula, which can cause serious infection in hospitalized cases. Healthy people are usually not infected with Candida auricula, which poses a low health threat to the general public.

　　Beijing CDC pointed out that the so-called "super fungus", named Candida auris, is a fungus that can cause serious infection in hospitalized cases. The data show that Candida auricula was discovered only in recent years and was first discovered in Japan in 2009. Through the retrospective detection of stored candida, it first appeared in South Korea in 1996.

　　According to statistics: At present, there are reports of cases of Candida auricula infection on all continents. As of February 28, 2019, there were 587 confirmed cases in the United States. There have been a few cases reported in China.

　　According to the Beijing CDC, because healthy people are usually not infected with Candida auricula, Candida auricula poses a low health threat to the general public, and the public need not panic or take special preventive measures.

　　Who is susceptible to Candida auricula infection? What are the main hazards?

　　Candida auricula can not only cause symptomatic infection, but also be carried in the body without symptoms. Candida auricula infection mainly involves hospitalized cases, and the high-risk population is patients with severe chronic basic diseases or immunosuppression (such as diabetes, chronic kidney disease, HIV infection, tumor, etc.); Newborns, patients with intubation or indwelling catheter, surgical patients and patients who use broad-spectrum antibiotics or antifungal drugs can also be infected. Healthy people usually don’t get candida auricula. The symptoms caused by Candida auricula depend on the location of infection, including bloodstream infection, wound infection and ear infection. Among them, bloodstream infection is the most serious, and the mortality rate can reach 30-40%.

　　What are the main treatments for this fungus at present?

　　At present, the fungus is mainly resistant to fluconazole, but the resistance to other antifungal drugs varies among different strains. At present, there are strains resistant to three main antifungal drugs. Most cases of Candida auricula infection can be treated with echinocandin antifungal agents, and cases of multi-drug resistant Candida auricula infection can be treated with high-dose and multi-antifungal agents.